Achromasia · What Is It, Causes, Diagnosis, Treatment, and More

Published: Aug 01, 2025
Author: Alyssa Haag , MD
Editor: Ahaana Singh
Editor: Lisa Miklush, PhD, RN, CNS
Illustrator: Abbey Richard, MSc
Copyeditor: Joy Mapes
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is achromasia?

Achromasia, also known as albinism, is a set of inherited disorders that cause scant or no production of melanin, a natural skin pigment. The type and amount of melanin an individual’s body produces determines the color of their skin, hair, and eyes. Melanin also has a role in the development of the optic nerve. 

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

What causes achromasia?

Achromasia results from inheriting a mutation in one of the several genes that are responsible for the production of melanin 

Oculocutaneous albinism (OCA) is the most common type of achromasia, and it occurs when an individual receives two copies of a mutated gene, one copy from each parent, called autosomal recessive inheritance. Inheritance of these mutations is a result of a mutation in one of the eight OCA genes, such as TYRTYRP1OCA2, among others. Mutations in OCA genes can cause decreased pigmentation in the skin, eyes, and hair, as well as the characteristic visual problems. An individual’s particular level of pigmentation depends on the specific OCA gene that is mutated.  

Ocular albinism type 1 is another common type of ocular albinism, although it occurs much less frequently than OCA and mainly causes visual problems. This type of achromasia is a recessive X-linked disorder: in female offspring, both inherited X chromosomes must have the mutation for the infant to express the disorder, whereas in male offspring, only the single X chromosome must contain the mutation for the infant to express the disorder. Accordingly, ocular albinism type 1 is most often passed down from mother to son and occurs most frequently in males.  

Finally, achromasia can occur alongside various rare hereditary disorders, such as Hermansky-Pudlak syndrome or Chiadek Higashi syndrome. Hermansky-Pudlak is a disorder that results in OCA, bleeding problems, and possible lung and colon issues. Chiadek Higashi syndrome is a rare immune disorder that often presents in childhood with OCA, immunodeficiency, and bleeding and bruising problems.  

What are the signs and symptoms of achromasia?

Accordingly, the common signs and symptoms of achromasia tend to affect the hair, skin, and eyes. Hair color of individuals with achromasia can range from white to brown; however, those of African or Asian descent may have yellowish or reddish hair. Hair color may darken with age but varies from person to person. Eyelashes and eyebrows are often very similar in hue to the individual’s hair color and are typically pale. Eye color can range from light blue to brown and, like hair color, can also darken with age. Skin coloring for those with achromasia ranges from white to brown, but it’s a less distinct sign of the condition since an individual with achromasia can have nearly the same skin tone as that of a parent or sibling who does not have achromasia. Individuals with achromasia are more prone to the formation of freckles, moles, and sunburns upon sun exposure. This increased sensitivity to sunlight lends to an increased risk of developing skin cancer 

Though hair, eyes, and skin are the most recognizable ways to identify achromasia, visual impairment is an additional key feature of achromasia. Visual impairments that may arise include an inability of both eyes to focus on the same point or move in unison, extreme nearsightedness, extreme farsightedness, or rapid and involuntary back and forth movements of the eye called nystagmus. Other common visual difficulties include sensitivity to light, abnormal curvature of the front of the eye causing blurred vision, abnormal retina development causing reduced vision, poor depth perception, and, in some cases, legal blindness.  

How is achromasia diagnosed and treated?

Diagnosis of achromasia is primarily based on a thorough review of medical history, family history, and a physical examination. The physical examination often includes an examination of the hair, skin, and eyes. Often, an individual’s pigmentation may be compared to that of their family members. Genetic testing and consultation can help to determine an individual’s specific type of albinism 

Since achromasia is an inherited disorder, it cannot be cured, so treatment is focused on monitoring and managing symptoms, as well as preventing further complications. A treatment regimen may include an annual eye and skin exam to monitor for potential issues, such as skin cancer. Individuals with achromasia may need visual aids and visual acuity support. Other lifestyle interventions include wearing sunscreen, protective clothing, and eye protection, especially while outside. It is also suggested that individuals with achromasia avoid long periods of sun exposure.  

What are the most important facts to know about achromasia?

Achromasia, also known as albinism, is a group of inherited disorders characterized by little or no production of melanin, the pigment responsible for the color of skin, hair, and eyes. It’s caused by mutations in genes responsible for melanin production, with oculocutaneous albinism (OCA) being the most common type. Achromasia can also be associated with rare syndromes like Hermansky-Pudlak and Chiadek Higashi. Achromasia is diagnosed using history, physical examination, and genetic testing to identify specific types of albinism. Treatment focuses on managing symptoms and preventing complications, including regular eye and skin exams, using visual aids, wearing sunscreen and protective clothing, and avoiding prolonged sun exposure. 

Key Takeaways

Definition 

Also known as albinism, a set of inherited disorders that cause scant or no production of melanin, the pigment responsible for the color of the skin, hair and eyes. 

Cause 

- Oculocutaneous albinism → autosomal recessive OCA genes mutations  

- Ocular albinism type 1 → recessive X-linked  

- Syndromes: Hermansky-Pudlak syndrome, Chiadek Higashi syndrome 

Signs and Symptoms 

- White to brown hair and eyelashes color; yellowish or reddish in those of African or Asian descent 

- Light blue to brown hair color 

- White to brown skin color 

- More prone to freckles, moles, and sunburns 

- Visual impairment 

Diagnosis 

- Review of family and medical history 

- Physical examination  

- Genetic testing and consultation 

Treatment 

- Inherited condition → no cure  

- Annual eye and skin exam 

- Visual aids and visual acuity support 

- Avoid extensive sun exposure, apply sunscreen and protective clothing 

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


Albinism. Mayo Clinic. Accessed January 21, 2021. https://www.mayoclinic.org/diseases-conditions/albinism/symptoms-causes/syc-20369184 


Baulier E, Garcia Diaz A, Corneo B, Farber DB. Generation of a human ocular albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Research. 2018;33:274-277. doi:https://doi.org/10.1016/j.scr.2018.11.016 


Boeckelmann D, Wolter M, Neubauer K, et al. Hermansky-Pudlak syndrome: Identification of novel variants in the genes HPS3, HPS5, and DTNBP1 (HPS-7). Front Pharmacol. 2022;12:786937. Published January 19, 2022. doi:10.3389/fphar.2021.786937. 


Bowman SL, Bi-Karchin J, Le L, Marks MS. The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases. Traffic. 2019;20(6):404-435. doi:10.1111/tra.12646. 


Morice-Picard F, Taïeb C, Marti A, Gliksohn A, Bennani M, Bodemer C, Ezzedine K; Filière maladies rares en dermatologie: FIMARAD. Burden of albinism: Development and validation of a burden assessment tool. Orphanet Journal of Rare Diseases. 2018;13(1):162. 


Teramae A, Kobayashi Y, Kunimoto H, et al. The molecular basis of chemical chaperone therapy for oculocutaneous albinism type 1A. J Invest Dermatol. 2019;139(5):1143-1149. doi:10.1016/j.jid.2018.10.033 


Wu XL, Zhao XQ, Zhang BX, Xuan F, Guo HM, Ma FT. A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase. Braz J Med Biol Res. 2017;50(4):e5727. Published March 23, 2017. doi:10.1590/1414-431X20165727.